PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Focus on Infection Control Boost Prospects of Peripheral Vascular Products in Western Europe Finds Frost & Sullivan - Infection control strategies and the rising demand for single-use medical devices are boosting the use of peripheral vascular products in western Europe
Focus on Infection Control Boost Prospects of Peripheral Vascular Products in Western Europe Finds Frost & Sullivan

 

NewswireToday - /newswire/ - London, United Kingdom, 2011/02/22 - Infection control strategies and the rising demand for single-use medical devices are boosting the use of peripheral vascular products in western Europe.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

At the same time, developments in imaging technology that are boosting the efficiency of angioplasty procedures are further advancing market prospects.

New analysis from Frost & Sullivan (medicaldevices.frost.com), Western European Markets for Peripheral Vascular Products, finds that overall market is set to expand. The following segments are covered in the research: centeripheral vascular stents and stent grafts, percutaneous transluminal angioplasty (PTA) catheters, endovascular catheters, guidewires, vascular closure systems (VCD) and embolic protection devices (EPD).

In most European countries, laws are in place advising against the reuse of single-use medical devices. However, single-use devices can be reused in Sweden as long as the devices meet the standards outlined in the medical device directives (MDD), the patient is informed and a vigilance system is maintained.

"The overall surgical procedure numbers are escalating throughout Europe with single-use medical devices being largely used in hospitals and as part of surgical procedures," notes Frost & Sullivan Senior Research Analyst Sree Vidhya Praveen. "The rise in the number of surgical procedures correlates positively with the increase in the use of single-use medical devices in the near future, boding well for peripheral vascular products."

Conventional X-ray fluoroscopy has been the standard approach used by interventional cardiologists or radiologists during procedures. Currently, digitalised cath labs have revolutionised the way interventional practitioners look at the organ or vessel.

Developments in imaging technology include improved contrast with lower doses of radiation and enhanced resolution. The introduction of intravascular ultrasound enables precise navigation of the balloon catheter through the vasculature. Additionally, they also aid in accomplishing proper dilation of the artery and in characterising the plaque.

These supporting domains are continuously under the influence of technological developments that enhance the efficiency of the interventional procedure. Such advances are set to have a positive impact on market growth.

One of the major challenges is gaining distinction among end users, despite the lack of significant differentiation among the number of products currently in the market. Due to the similarity of products, many surgeons tend to make selections based on the familiarity of a specific brand name.

"Interventionalists are by no means myopic with their device selection; they do not see a significant margin of distinction between the newer devices and their preferred device to warrant usage," states Praveen. "If presented with a device with appreciable benefits and notable clinical benchmarks, it is likely they would not hesitate to incorporate the newer technology."

The rapid pace of technology evolution demands high investments in R&D. Certain product segments included within the western European market for devices used to treat peripheral vessel disease are notable for the rapid pace of technological development and the speed with which new products are launched.

Companies that are unable to keep pace with such change are likely to experience diminishing market shares. R&D and the acquisition of small companies known for their innovative excellence are both commonly used strategies that enable companies to bring new technology to market and gain market share.

Due to the wide range of devices with similar features available in the market, being able to develop a technologically advanced product line is critical to success. Most importantly, given the inordinate length of time it takes to design a device, gain regulatory approval, and the resulting encumbered speed to market, most participants want to ensure that they maximise their market penetration.

"Launching a new device with only a marginal benefit over existing products on the market might only have a slight impact, ensuring a firm gets inadequate return on its investments," concludes Praveen. "However, instead of launching a 'me-too' device, a product offering significant leap in terms of technology would create significant industry buzz and accelerate its adoption in the market. Firms need to make themselves aware of the features that will best serve the market six to seven years down the line."

If you are interested in more information about Frost & Sullivan's latest study Western European Markets for Peripheral Vascular Products, please send an email with your complete contact details to Katja Feick, Corporate Communications, at katja.feick[.]frost.com.

Western European Markets for Peripheral Vascular Products is part of the Medical Devices Growth Partnership Services programme, which also includes research in the following markets: Western European Markets for Peripheral Vascular Products, Overview of the Western European Peripheral Interventional Devices Market, European Blood Banking Devices Market and European Disinfection Gels and Scrubs Market, among others. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost & Sullivan
Frost & Sullivan (frost.com), the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents.

Western European Markets for Peripheral Vascular Products / M68F.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Focus on Infection Control Boost Prospects of Peripheral Vascular Products in Western Europe Finds Frost & Sullivan

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan |
Publisher Contact: Katja Feick 
+49 (0) 69 7703343 katja.feick[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

Thales Launches the Pixium Portable 3543 DR Wifi Enabled Flat Panel Detector
GE Healthcare Showcases Industry-first Technologies and Digital Solutions, Focused on Improving Outcomes, At RSNA 2016
Agfa and LCsys Team Up to Launch ABSOLUT-ID, Their Turnkey Integrated Solution for the Production of High Security ID Cards
ZOLL Technology for Improving CPR Quality to be Showcased at American Heart Association Annual Conference
AccuVein to Exhibit Leading Vein Visualization Technology at American Society for Dermatologic Surgery Annual Meeting
US Biomedical Textiles Transform Implant Device Technology by Aligning to Changes in Patient Preference Finds Frost & Sullivan
Frost & Sullivan Commends Influence Health for Constantly Evolving its Patient Engagement Products to Accelerate Market Transformation
Frost & Sullivan Awards Carestream Top Honors for OnSight 3D Extremity System
Sparta Systems Launches the Next-Generation Cloud Solution Stratas QMS
Koning Wins Accolades from Frost & Sullivan for the Impressive Innovation Behind its Groundbreaking KBCT Breast Imaging Device
Frost & Sullivan Awards ResMed for Developing S+ Advanced Sleep Tracking System
Sparta Systems Becomes First Quality Management Solutions Provider to Achieve EU-U.S. Privacy Shield Compliance
ZOLL Expands the Rescuer Experience at EMS World Expo
Agfa and GPMI Sign Distribution Agreement for Agfa’s Synthetic Paper Synaps
Frost & Sullivan Highlights iLine Microsystems for Developing a Microfluidics-Based Sophisticated POC Device for PT/INR Coagulation Testing

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  Triggr & Bloom





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)